Managed Account Advisors’s Lifecore Biomedical LFCR Stock Holding History

Managed Account Advisors’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$1.27M	Sell	88,078 -23,099	-21%	-$333K	﹤0.01%	2017
2015 Q1	$1.55M	Sell	111,177 -15,413	-12%	-$213K	﹤0.01%	1959
2014 Q4	$1.75M	Sell	126,590 -3,034	-2%	-$39.2K	﹤0.01%	1871
2014 Q3	$1.59M	Buy	129,624 +38,767	+43%	+$484K	﹤0.01%	1898
2014 Q2	$1.14M	Sell	90,857 -9,463	-9%	-$111K	﹤0.01%	1973
2014 Q1	$1.12M	Buy	100,320 +1,173	+1%	+$12.9K	﹤0.01%	1926
2013 Q4	$1.2M	Buy	99,147 +7,271	+8%	+$86.8K	﹤0.01%	1870
2013 Q3	$1.12M	Sell	91,876 -1,104	-1%	-$15.4K	﹤0.01%	1859
2013 Q2	$1.23M	Buy	+92,980	New	+$1.29M	﹤0.01%	1801

Other funds holding LFCR

Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

NIMC

NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Killen Group Berwyn, Pennsylvania $866M AUM 0.25% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Managed Account Advisors's LFCR Position: Q2 2015 in Review

Managed Account Advisors reduced its Lifecore Biomedical (LFCR) stake by 21% in Q2 2015, selling an estimated $333K and leaving 88,078 shares worth $1.27M. The position accounts for ﹤0.01% of the portfolio, ranked #2017.

Managed Account Advisors first reported a position in LFCR in Q2 2013 and has held it in 9 quarters since. The position peaked at $1.75M in Q4 2014. 108 funds tracked by Wall St. Rank hold LFCR as of Q2 2015.

Managed Account Advisors held 88,078 shares of Lifecore Biomedical worth $1.27M as of Q2 2015.
Managed Account Advisors sold 23,099 Lifecore Biomedical shares in Q2 2015, an estimated $333K.
Lifecore Biomedical made up ﹤0.01% of Managed Account Advisors's portfolio in Q2 2015, its #2017 holding.
Managed Account Advisors first reported a position in Lifecore Biomedical in Q2 2013 and has held it in 9 quarters since.
Managed Account Advisors's Lifecore Biomedical position peaked at $1.75M in Q4 2014.
108 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.